To compare the surgical precision for optimizing nephron-mass preservation of tumor enucleation (TE) vs standard partial nephrectomy (SPN), with primary focus on functional outcomes. TE is presumed to optimize preservation of parenchymal mass and function but this has not yet been rigorously studied and quantified.
Materials and Methods
Robotic partial nephrectomy patients who had appropriate pre- and postoperative studies for analysis of parenchymal mass preservation specific to the operated kidney were included. Computed tomography or magnetic resonance imaging and estimated glomerular filtration rate were required to be <2 months prior and 4-12 months after surgery. Parenchymal mass preservation and surgical precision were estimated for each technique, with precision defined as actual postoperative parenchymal volume or predicted postoperative parenchymal volume, presuming loss of a 5 mm rim of parenchyma associated with tumor excision and reconstruction.
Analysis included 57 TE and 53 SPN. Median age, body mass index, and tumor size were comparable. Percent parenchymal mass preserved in the operated kidney with TE was 96% (interquartile range [IQR] = 90-100) vs 89% (IQR = 83-96) for SPN (P = .003). Precision of excision or reconstruction was 101% (IQR = 96-105) for TE vs 94% (IQR = 88-100) for SPN (P < .001). On multivariable analysis, only TE correlated with improved surgical precision (coefficient = 6.7, 95% confidence interval = 1.6-11.8, P = .01). Although preservation of global renal function also favored TE, the differences were marginal (96% vs 93%), and statistical significance was not observed (P = .2).
Our analysis, which specifically focuses on the functional implications of TE, demonstrates that TE maximally spares normal parenchyma compared to SPN. Thus far, functional differences remain marginal and not statistically significant. Clinical significance of these findings in various clinical settings will require further investigation.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Urology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.Eur Urol. 2014; 65: 372-377
- Guideline for management of the clinic T1 renal mass.J Urol. 2009; 182: 1271-1279
- EAU guidelines on renal cell carcinoma: 2014 update.Eur Urol. 2015; 67: 913-924
- Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function.J Urol. 2006; 176: 1339-1343
- Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury.J Urol. 2012; 187: 1667-1673
- Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney.Urology. 2012; 79: 356-360
- Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis.Urology. 2013; 82: 263-268
- Functional recovery from extended warm ischemia associated with partial nephrectomy.Urology. 2015; 87: 106-113
- Decline in renal function after partial nephrectomy: etiology and prevention.J Urol. 2015; 193: 1889-1898
- Tumor enucleation for sporadic localized kidney cancer: pro and con.J Urol. 2015; 194: 623-625
- Simple enucleation for the treatment of pT1a renal cell carcinoma: our 20 year experience.Eur Urol. 2006; 50: 1269-1271
- Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study.J Urol. 2011; 185: 1604-1610
- Simple enucleation for renal tumors: indications, techniques, and results.Curr Urol Rep. 2016; 17: 7
- Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation.Urol Oncol. 2014; 32 (e15-22): 50
- Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project).Eur J Surg Oncol. 2014; 40: 762-768
- Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma.Eur Urol. 2014; 55: 1410-1418
- Histological analysis of the kidney tumor-parenchyma interface.J Urol. 2015; 193: 415-422
- Predictors of precision of excision and reconstruction in partial nephrectomy.J Urol. 2014; 192: 30-35
- The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.J Urol. 2009; 182: 844-853
- A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis. 1987; 40: 373-383
- A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.Ann Intern Med. 1999; 130: 461-470
- Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival.J Urol. 2014; 192: 1057-1062
- Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate.Eur Urol. 2015; 68: 996-1003
- Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease.J Urol. 2013; 189: 1649-1655
- Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.J Urol. 2012; 188: 2084-2088
- Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery.Eur Urol. 2016; 69: 745-752
- Tumor enucleation vs. sharp dissection in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes.Urology. 2014; 83: 1294-1299
Published online: September 07, 2016
Accepted: July 21, 2016
Received: May 17, 2016
Financial Disclosure: The authors declare that they have no relevant financial interests.
© 2016 Elsevier Inc. All rights reserved.